Altered peripheral toll‐like receptor responses in the irritable bowel syndrome
暂无分享,去创建一个
T. Dinan | J. Cryan | D. McKernan | E. Quigley | J. Cryan | T. Dinan | G. Gaszner | D. McKernan | E. M. Quigley | Ted G. Dinan
[1] A. Fanning,et al. Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome , 2011, The American Journal of Gastroenterology.
[2] P. Scully,et al. Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity , 2010, The American Journal of Gastroenterology.
[3] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[4] L. Öhman,et al. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions , 2010, Nature Reviews Gastroenterology &Hepatology.
[5] T. Dinan,et al. Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome , 2009, PloS one.
[6] E. Mayer,et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. , 2009, Gastroenterology.
[7] T. Dinan,et al. Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.
[8] H. Strid,et al. B‐cell activation in patients with irritable bowel syndrome (IBS) , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[9] E. Mayer,et al. Principles and clinical implications of the brain–gut–enteric microbiota axis , 2009, Nature Reviews Gastroenterology &Hepatology.
[10] L. Öhman,et al. T-Cell Activation in Patients With Irritable Bowel Syndrome , 2009, The American Journal of Gastroenterology.
[11] J. Ceuppens,et al. Immune dysfunction in patients with functional gastrointestinal disorders , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[12] P. Scully,et al. Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.
[13] J. Sheridan,et al. Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion , 2009, Brain, Behavior, and Immunity.
[14] P. Baldi,et al. Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[15] J. Miao,et al. Chronic restraint stress promotes immune suppression through Toll-like receptor 4-mediated phosphoinositide 3-kinase signaling , 2008, Journal of Neuroimmunology.
[16] M. Kamm,et al. Review article: the psychoneuroimmunology of irritable bowel syndrome – an exploration of interactions between psychological, neurological and immunological observations , 2008, Alimentary pharmacology & therapeutics.
[17] R. Ji,et al. Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord , 2008, The Journal of Neuroscience.
[18] Baoxiang Zhao,et al. Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression , 2008, Journal of Neuroimmunology.
[19] J. Sheridan,et al. Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[20] J. Corander,et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. , 2007, Gastroenterology.
[21] A. Bowie,et al. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.
[22] Gerald Holtmann,et al. Immune activation in patients with irritable bowel syndrome. , 2007, Gastroenterology.
[23] P. Scully,et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? , 2006, Gastroenterology.
[24] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[25] E. Quigley. Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon. , 2005, Gastroenterology clinics of North America.
[26] M. Nishimura,et al. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. , 2005, Biological & pharmaceutical bulletin.
[27] J. Kiecolt-Glaser,et al. Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.
[28] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[29] J. Cidlowski,et al. Glucocorticoids and Tumor Necrosis Factor Alpha Cooperatively Regulate Toll-Like Receptor 2 Gene Expression , 2004, Molecular and Cellular Biology.
[30] Jiahuai Han,et al. Glucocorticoids synergize with IL-1β to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells , 2004, BMC Molecular Biology.
[31] Y. Taché,et al. CRF1 receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome , 2004, British journal of pharmacology.
[32] J. Buckingham,et al. Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis. , 2003, Current opinion in pharmacology.
[33] E. Quigley,et al. Current Concepts of the Irritable Bowel Syndrome , 2003, Scandinavian journal of gastroenterology. Supplement.
[34] D. Drossman,et al. AGA technical review on irritable bowel syndrome. , 2002, Gastroenterology.
[35] Wangxue Chen,et al. Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.
[36] E. Mayer,et al. Evolving pathophysiologic models of functional gastrointestinal disorders. , 2002, Gastroenterology.
[37] Y. Taché,et al. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[38] R. Spitzer,et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.
[39] K W Heaton,et al. Functional bowel disorders and functional abdominal pain , 1999, Gut.
[40] P. Whorwell,et al. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.
[41] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[42] Wilfrid Jänig,et al. Visceral nociceptors: a new world order? , 1992, Trends in Neurosciences.
[43] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[44] A. Craig,et al. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Neuroimaging of the Brain-Gut Axis: From Basic Understanding to Treatment of Functional GI Disorders , 2006 .